Loading...
Market
Will CVS's Q4 2024 adjusted EPS exceed $1.10?
3
Resolution / Starting Odds
Yes • 50%
No • 50%
CVS's official earnings report or financial news outlets like Bloomberg or Reuters
Story
CVS Replaces CEO Karen Lynch with David Joyner as Earnings Miss; Shares Plunge 13%
Oct 18, 2024, 10:36 AM
CVS Health Corp. has appointed longtime executive David Joyner as its new President and Chief Executive Officer, replacing Karen Lynch who stepped down following a tumultuous tenure and an agreement with the board. The leadership change coincides with the company's warning of lower third-quarter earnings, citing medical cost trends exceeding prior projections, including a Medical Loss Ratio of 95% versus expectations of 91%. Preliminary Q3 adjusted earnings per share are expected to be between $1.05 and $1.10, significantly below estimates and the company's previous outlook issued in August. The healthcare giant is backing away from its 2024 guidance amid a hit to its Medicare Advantage business. Following the announcements, CVS shares sank as much as 13%, reflecting investor concerns over the company's financial performance and strategic direction.
View original story
Similar markets
Below $1.00 • 25%
$1.00 to $1.10 • 25%
$1.11 to $1.20 • 25%
Above $1.20 • 25%
Below $1.00 • 25%
$1.00 to $1.50 • 25%
Above $1.50 • 25%
Other • 25%
Revenue increases • 25%
Revenue decreases • 25%
Net income increases • 25%
Net income decreases • 25%
